Manufacturers Life Insurance Company, The Pulse Biosciences, Inc. Transaction History

Manufacturers Life Insurance Company, The

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$16.31 - $23.64 $138,471 - $200,703	-8,490 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$22.43 - $44.27 $16,172 - $31,918	-721 Reduced 7.83%	8,490 $201,000
Q4 2020 Feb 12, 2021	BUY	$11.66 - $24.5 $107,400 - $225,669	9,211 New	9,211 $220,000
Q3 2018 Nov 14, 2018	SELL	$12.83 - $16.45 $76,787 - $98,453	-5,985 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$14.04 - $20.28 $77,893 - $112,513	5,548 Added 1269.57%	5,985 $90,000
Q1 2018 May 15, 2018	SELL	$12.67 - $24.69 $86,890 - $169,324	-6,858 Reduced 94.01%	437 $6,000
Q4 2017 Feb 08, 2018	BUY	$18.81 - $30.33 $129,939 - $209,519	6,908 Added 1785.01%	7,295 $172,000
Q3 2017 Nov 14, 2017	BUY	$10.26 - $24.97 $3,970 - $9,663	387	387 $7,000

5.41M

139K

84.2K

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $675M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.